Sara Rothschild, Executive Director and Vice President of The Life Raft Group, shared a post on X:
”Great opportunity to meet Dr. Mark Dickson, PI of SARC41 trial of abemaciclib vs. placebo.
The lipo patient community is encouraged by this study and hopeful for future trials so patients have more options for survival. Met with media to ensure the patient voice was represented.”
Other Articles Featuring Sara Rothschild On OncoDaily.